The bio-psycho-social model and the American Diabetes Association European Association for the Study of Diabetes position statement on management of hyperglycemia

Introduction

The current joint position statement of the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) makes a strong call for a patient-centered approach to the management of hyperglycemia in type 2 diabetes.[1] The position statement discusses the background, rationale, and definition of this approach. It highlights glycemic targets, available therapeutic options, implementation strategies, while noting other considerations in planning management of hyperglycemia. Various factors which determine the choice of glycemic targets, therapeutic interventions, and management strategies, are analysed in detail. The concordance of this statement with the bio-psycho-social model of health and disease are discussed here.

• References

• 1 Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M. et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596
• 2 Engel GL. The need for a new medical model: A challenge for biomedicine. Science 1977; 196: 129-136
• 3 Adler RH. Engel's biopsychosocial model is still relevant today. J Psychosom Res 2009; 67: 607-611
• 4 Kalra S, Baruah M, Ganapathy M, Ganie A, Sahay R, Unnikrishnan A. Patient centred approach to diabetes management: The DAWN philosophy. Internet J Fam Pract 2010; 8
• 5 Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: Implications of recent clinical trials. Ann Intern Med 2011; 154: 554-559